| scholarly article | Q13442814 |
| P2093 | author name string | Shevach EM | |
| Thornton AM | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 183-190 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific | |
| P478 | volume | 164 |
| Q37049504 | 25 years of UV-induced immunosuppression mediated by T cells-from disregarded T suppressor cells to highly respected regulatory T cells |
| Q35990046 | A TLR4 agonist synergizes with dendritic cell-directed lentiviral vectors for inducing antigen-specific immune responses |
| Q34644052 | A bovine whey protein extract can induce the generation of regulatory T cells and shows potential to alleviate asthma symptoms in a murine asthma model |
| Q35143924 | A dual altered peptide ligand down-regulates myasthenogenic T cell responses by up-regulating CD25- and CTLA-4-expressing CD4+T cells |
| Q34231824 | A low interleukin-2 receptor signaling threshold supports the development and homeostasis of T regulatory cells |
| Q42775633 | A mathematical model of immune activation with a unified self-nonself concept |
| Q33865874 | A peripheral circulating compartment of natural naive CD4 Tregs |
| Q30479825 | A role for natural regulatory T cells in the pathogenesis of experimental cerebral malaria |
| Q36389642 | A simple mechanistic explanation for original antigenic sin and its alleviation by adjuvants |
| Q42284529 | A subset of CD8+ T cells acquiring selective suppressive properties may play a role in GvHD management |
| Q36933695 | A20 is an antigen presentation attenuator, and its inhibition overcomes regulatory T cell-mediated suppression |
| Q35172102 | About CD4pos CD25pos regulatory cells |
| Q45111137 | Absence of CD4+CD25+ regulatory T cells is associated with a loss of regulation leading to increased pathology in Helicobacter pylori-infected mice |
| Q35848308 | Activated CD4+CD25+ T cells selectively kill B lymphocytes |
| Q79415991 | Activation of CD4+ CD25+ regulatory T cell suppressor function by analogs of the selecting peptide |
| Q44866798 | Adoptive immunotherapy with allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes for recurrent, EBV-positive Hodgkin disease |
| Q43842949 | Age associated decline in CD25 and CD28 expression correlate with an increased susceptibility to CD95 mediated apoptosis in T cells |
| Q56901055 | Age-related changes in the occurrence and characteristics of thymic CD4(+) CD25(+) T cells in mice |
| Q35101760 | Agent based modeling of Treg-Teff cross regulation in relapsing-remitting multiple sclerosis |
| Q36026031 | Allergic airway inflammation |
| Q35578769 | Alloantigen-enhanced accumulation of CCR5+ 'effector' regulatory T cells in the gravid uterus |
| Q83485975 | Allogeneic apoptotic thymocyte-stimulated dendritic cells expand functional regulatory T cells |
| Q56899929 | Allogeneic induced human FOXP3(+)IFN-gamma(+) T cells exhibit selective suppressive capacity |
| Q38236300 | Alteration of regulatory T cells in type 1 diabetes mellitus: a comprehensive review. |
| Q78008037 | An established immune response against ovalbumin is suppressed by a transferable serum factor produced after ovalbumin feeding: a role of CD25+ regulatory cells |
| Q43636357 | An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. |
| Q35973425 | An innately interesting decade of research in immunology |
| Q35769472 | An integrated model of immunoregulation mediated by regulatory T cell subsets |
| Q35936478 | An integrated view of suppressor T cell subsets in immunoregulation |
| Q80059469 | Analysis of CD4+ CD25+ regulatory T cells and Foxp3 mRNA in the peripheral blood of patients with asthma |
| Q34604727 | Analysis of adhesion molecules, target cells, and role of IL-2 in human FOXP3+ regulatory T cell suppressor function |
| Q33958418 | Anergic T cells as active regulators of the immune response |
| Q35176352 | Anergy and suppression as coexistent mechanisms for the maintenance of peripheral T cell tolerance |
| Q36360525 | Animal models of allergen-induced tolerance in asthma: are T-regulatory-1 cells (Tr-1) the solution for T-helper-2 cells (Th-2) in asthma? |
| Q34096254 | Animal models of autoimmunity and their relevance to human diseases |
| Q41712619 | Anti-CD4-mediated selection of Treg in vitro - in vitro suppression does not predict in vivo capacity to prevent graft rejection |
| Q40435122 | Anti-OX40L alone or in combination with anti-CD40L and CTLA4Ig does not inhibit the humoral and cellular response to a major grass pollen allergen |
| Q53663389 | Antigen-dependent suppression of alloresponses by Foxp3-induced regulatory T cells in transplantation. |
| Q42126452 | Antigen-induced IL-10+ regulatory T cells are independent of CD25+ regulatory cells for their growth, differentiation, and function |
| Q41810048 | Antigen-non-specific regulation centered on CD25+Foxp3+ Treg cells |
| Q54363666 | Antigen-specific T-regulatory cells can extend skin graft survival time in mice. |
| Q37381562 | Antigen-specific induced T regulatory cells impair dendritic cell function via an IL-10/MARCH1-dependent mechanism |
| Q84748573 | Antigen-specific recognition is critical for the function of regulatory CD8(+)CD28(-) T cells |
| Q35129735 | Apoptosis and transplantation tolerance. |
| Q37270469 | Apoptosis as a mechanism of T-regulatory cell homeostasis and suppression |
| Q33786819 | Apoptosis of purified CD4+ T cell subsets is dominated by cytokine deprivation and absence of other cells in new onset diabetic NOD mice |
| Q45340759 | Application of dendritic cells stimulated with Trichinella spiralis excretory-secretory antigens alleviates experimental autoimmune encephalomyelitis. |
| Q42185296 | Are we ready for the use of foxp3(+) regulatory T cells for immunodiagnosis and immunotherapy in kidney transplantation? |
| Q37045670 | Assessing the in vitro suppressive capacity of regulatory T cells |
| Q37595104 | Association of CD4+ CD25+ T cells with prevention of severe destructive arthritis in Borrelia burgdorferi-vaccinated and challenged gamma interferon-deficient mice treated with anti-interleukin-17 antibody |
| Q45132751 | Association of high anti-donor alloreactivity and low frequency of FoxP3-expressing cells prior to kidney transplantation with acute graft rejection. |
| Q35573371 | Autoimmune Diseases as the Loss of Active “Self‐Control” |
| Q36522843 | Autoimmunity: basic mechanisms and implications in endocrine diseases. Part II. |
| Q54641462 | Autoreactive human peripheral blood CD8+ T cells with a regulatory phenotype and function. |
| Q28204573 | B cells and professional APCs recruit regulatory T cells via CCL4 |
| Q42502298 | B-cell-delivered gene therapy induces functional T regulatory cells and leads to a loss of antigen-specific effector cells |
| Q36376571 | Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis |
| Q84971931 | Beneficial cross-protection of allergen-specific immunotherapy on airway eosinophilia using unrelated or a partial repertoire of allergen(s) implicated in experimental feline asthma |
| Q28307216 | Biologic and immunomodulatory events after CTLA-4 blockade with ticilimumab in patients with advanced malignant melanoma |
| Q36251308 | Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD). |
| Q63976823 | Bronchus-associated lymphoid tissue-resident Foxp3+ T lymphocytes prevent antibody-mediated lung rejection |
| Q33416251 | CD(+)(4)CD(+)(25) Treg cells in thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus patients |
| Q36399104 | CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. |
| Q36232697 | CD25+ CD4+ regulatory T-cells in cancer |
| Q73862255 | CD25+, interleukin-10-producing CD4+ T cells are required for suppressor cell production and immune privilege in the anterior chamber of the eye |
| Q34066063 | CD25+CD4+ T cells contribute to the control of memory CD8+ T cells |
| Q24805444 | CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease |
| Q44548657 | CD4 (+)CD 25 (+)Treg cells and IgA nephropathy patients with tonsillectomy: a clinical and pathological study |
| Q74660381 | CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2 |
| Q42575046 | CD4(+) CD25(+) FoxP3(+) regulatory T cells suppress cytotoxicity of CD8(+) effector T cells: implications for their capacity to limit inflammatory central nervous system damage at the parenchymal level. |
| Q34418015 | CD4(+) regulatory T cells |
| Q37317928 | CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus |
| Q36986140 | CD4(+)CD25(+) T Cells in primary malignant hypertension related kidney injury |
| Q36369151 | CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade |
| Q34525987 | CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease |
| Q34116317 | CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor |
| Q36370807 | CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness |
| Q56901953 | CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers |
| Q44695045 | CD4+ CD25+ CD62+ T-regulatory cell subset has optimal suppressive and proliferative potential |
| Q53666742 | CD4+ CD25+ FOXP3+ regulatory T cells from human thymus and cord blood suppress antigen-specific T cell responses. |
| Q35694441 | CD4+ CD25+ Treg: divide and rule? |
| Q79629254 | CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive |
| Q34571847 | CD4+ CD25+ regulatory T cells suppress contact hypersensitivity reactions by blocking influx of effector T cells into inflamed tissue |
| Q34716304 | CD4+ CD25+ suppressor T cells: more questions than answers |
| Q78766784 | CD4+ T regulatory cells from the colonic lamina propria of normal mice inhibit proliferation of enterobacteria-reactive, disease-inducing Th1-cells from scid mice with colitis |
| Q40624661 | CD4+CD25+ T Cells Lyse Antigen-Presenting B Cells by Fas-Fas Ligand Interaction in an Epitope-Specific Manner |
| Q36371702 | CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses |
| Q35978587 | CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes |
| Q34063120 | CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2. |
| Q24673863 | CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms |
| Q36275650 | CD4+CD25+ cells in multiple myeloma related renal impairment |
| Q36600237 | CD4+CD25+ regulatory T cell therapy for the induction of donor-specific clinical transplantation tolerance |
| Q44643759 | CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells. |
| Q53517484 | CD4+CD25+ regulatory T cells have divergent effects on intestinal inflammation in IL-10 gene-deficient mice. |
| Q37905796 | CD4+CD25+ regulatory T cells in systemic sclerosis and other rheumatic diseases |
| Q36403637 | CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner |
| Q35216473 | CD4+CD25+ regulatory T cells mediate acquired transplant tolerance |
| Q33614706 | CD4+CD25+ regulatory T cells restrain pathogenic responses during Leishmania amazonensis infection |
| Q40416864 | CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism |
| Q35985217 | CD4+CD25+ regulatory T cells: I. Phenotype and physiology |
| Q36386905 | CD4+CD25+ regulatory T lymphocytes in bone marrow transplantation |
| Q37754524 | CD4+CD25+ regulatory T-cell therapy |
| Q36223583 | CD4+CD25+-regulatory T cells from mouse to man. |
| Q34709777 | CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells |
| Q92538754 | CD4+FOXP3+ Regulatory T Cell Therapies in HLA Haploidentical Hematopoietic Transplantation |
| Q36169760 | CD4CD25 regulatory T lymphocytes in allergy and asthma |
| Q37017450 | CD5 plays an inhibitory role in the suppressive function of murine CD4(+) CD25(+) T(reg) cells |
| Q45597208 | CD8+ T cells reduce in vitro interferon-gamma production in Theiler's murine encephalomyelitis virus-induced demyelinating disease model |
| Q47692038 | CD8+CD122+ regulatory T cells recognize activated T cells via conventional MHC class I-alphabetaTCR interaction and become IL-10-producing active regulatory cells. |
| Q33800533 | Can antigen-specific regulatory T cells protect against graft versus host disease and spare anti-malignancy alloresponse? |
| Q37986999 | Cancer immunoediting in malignant glioma |
| Q34517421 | Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta |
| Q78049706 | Cellular immune responses in Helicobacter heilmannii infection: evaluation of the role of the host and the bacterium |
| Q37695090 | Cellular mediators of inflammation: tregs and TH17 cells in gastrointestinal diseases. |
| Q36369181 | Certified professionals: CD4(+)CD25(+) suppressor T cells |
| Q37421478 | Changes in cellular proliferation and plasma products are associated with liver failure |
| Q34374565 | Characterisation of thymus-derived regulatory T cells that protect against organ-specific autoimmune disease |
| Q56902065 | Characteristics of rat CD4(+)CD25(+) T cells and their ability to prevent not only diabetes but also insulitis in an adoptive transfer model in BB rats |
| Q58966944 | Characterization and functional analysis of cellular immunity in mice with biotinidase deficiency |
| Q52012409 | Characterization of human CD25+ CD4+ T cells in thymus, cord and adult blood. |
| Q36490768 | Checkpoint blockade in cancer immunotherapy |
| Q37486824 | Chronic follicular bronchiolitis requires antigen-specific regulatory T cell control to prevent fatal disease progression |
| Q35083337 | Chronic inhaled ovalbumin exposure induces antigen-dependent but not antigen-specific inhalational tolerance in a murine model of allergic airway disease |
| Q56900910 | Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection |
| Q36150414 | Clinical application of human CD4+ CD25+ regulatory T cells for the treatment of inflammatory bowel diseases |
| Q37078189 | Clinical significance of monitoring circulating CD4+CD25+ regulatory T cells in kidney transplantation during the early posttransplant period |
| Q37600964 | Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells |
| Q39761212 | Co-inhibitory molecules: Controlling the effectors or controlling the controllers? |
| Q28271806 | Co-stimulatory pathways in lymphocyte regulation: the immunoglobulin superfamily |
| Q36485931 | Coinhibitory T-cell signaling in islet allograft rejection and tolerance |
| Q47100613 | Combining Adoptive Treg Transfer with Bone Marrow Transplantation for Transplantation Tolerance |
| Q41432392 | Comparative analysis of cellular immune responses and cytokine levels in sheep experimentally infected with bluetongue virus serotype 1 and 8. |
| Q84300301 | Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation |
| Q36371658 | Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. |
| Q36054301 | Continuum model of T-cell avidity: Understanding autoreactive and regulatory T-cell responses in type 1 diabetes |
| Q35190025 | Contrasting effects of TNF and anti-TNF on the activation of effector T cells and regulatory T cells in autoimmunity |
| Q35623006 | Control of autoimmunity by naturally arising regulatory CD4+ T cells |
| Q42944823 | Control of immune responses by naturally arising CD4+ regulatory T cells that express toll-like receptors |
| Q34374577 | Control of organ-specific autoimmunity by immunoregulatory CD4(+)CD25(+) T cells |
| Q36242785 | Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice. |
| Q37392233 | Control of type 1 diabetes by CD4+Foxp3+ regulatory T cells: lessons from mouse models and implications for human disease |
| Q34137298 | Cord blood derived CD4+ CD25(high) T cells become functional regulatory T cells upon antigen encounter |
| Q83554638 | Correlation between the cord vitamin D levels and regulatory T cells in newborn infants |
| Q45007213 | Crucial role of CD4+CD 25+ FOXP3+ T regulatory cell, interferon-γ and interleukin-16 in malignant and tuberculous pleural effusions |
| Q42821897 | Curcumin induces maturation-arrested dendritic cells that expand regulatory T cellsin vitroandin vivo |
| Q42617070 | Curing CNS autoimmune disease with myelin-reactive Foxp3+ Treg |
| Q89727168 | Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma |
| Q37349582 | Cutting edge: regulatory T cells do not require stimulation through their TCR to suppress |
| Q52856887 | Cytokines affecting CD4+T regulatory cells in transplant tolerance. III. Interleukin-5 (IL-5) promotes survival of alloantigen-specific CD4+ T regulatory cells. |
| Q33246674 | Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression |
| Q52013964 | Decreased total numbers of peripheral blood lymphocytes with elevated percentages of CD4+CD45RO+ and CD4+CD25+ of T-helper cells in non-segmental vitiligo. |
| Q45043921 | Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season |
| Q56900405 | Deficiency of forkhead box P3 and cytotoxic T-lymphocyte-associated antigen-4 gene expressions and impaired suppressor function of CD4(+)CD25(+) T cells in patients with autoimmune hepatitis |
| Q34004810 | Dendritic cell-regulatory T-cell interactions control self-directed immunity |
| Q34295082 | Dendritic cells as a tool to induce anergic and regulatory T cells |
| Q36563563 | Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity. |
| Q35669757 | Dendritic cells with TGF-beta1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells |
| Q47794906 | Dendritic cells, engineered to secrete a T-cell receptor mimic peptide, induce antigen-specific immunosuppression in vivo |
| Q79780581 | Depletion of CD4+CD25+ regulatory T cells exacerbates sodium iodide-induced experimental autoimmune thyroiditis in human leucocyte antigen DR3 (DRB1*0301) transgenic class II-knock-out non-obese diabetic mice |
| Q79435561 | Development of CD25- regulatory T cells following heart transplantation: evidence for transfer of long-term survival |
| Q83153136 | Development of a capture ELISA to determine kinetics of soluble CD25 following in vitro and in vivo stimulation of duck peripheral blood monocytes |
| Q36490753 | Development of antibodies and chimeric molecules for cancer immunotherapy |
| Q64988693 | Differential Regulation of T-cell mediated anti-tumor memory and cross-protection against the same tumor in lungs versus skin. |
| Q45373146 | Differential effect of CD4+Foxp3+ T-regulatory cells on the B and T helper cell responses to influenza virus vaccination |
| Q54442285 | Differential recognition of heat-shock protein dnaJ-derived epitopes by effector and Treg cells leads to modulation of inflammation in juvenile idiopathic arthritis. |
| Q36371345 | Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells |
| Q37227053 | Distinct contributions of CD4+ T cell subsets in hepatic ischemia/reperfusion injury |
| Q46468450 | Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function |
| Q51975593 | Distinctive role of CCR7 in migration and functional activity of naive- and effector/memory-like Treg subsets. |
| Q59048750 | Do Foxp3+ Regulatory T Cells (Treg Cells) Play a Role in the Immunopathogenesis of Primary/Idiopathic Minimal Change Disease? |
| Q37065735 | Do Natural T Regulatory Cells become Activated to Antigen Specific T Regulatory Cells in Transplantation and in Autoimmunity? |
| Q37015369 | Does inflammation in an autoimmune disease differ from inflammation in neurodegenerative diseases? Possible implications for therapy |
| Q35865098 | Donor-derived, tolerogenic dendritic cells suppress immune rejection in the indirect allosensitization-dominant setting of corneal transplantation |
| Q36370863 | Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation |
| Q36604797 | Double-negative regulatory T cells: non-conventional regulators |
| Q37569879 | Dual effect of CD4+CD25+ regulatory T cells in neurodegeneration: a dialogue with microglia |
| Q30583272 | Dynamic Treg interactions with intratumoral APCs promote local CTL dysfunction |
| Q51673772 | Dynamics of immunological models. |
| Q33993967 | Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation |
| Q94375931 | EFFECT OF LIPOSOMAL CLODRONATE-DEPENDENT DEPLETION OF PROFESSIONAL ANTIGEN PRESENTING CELLS ON NUMBERS AND PHENOTYPE OF CANINE CD4+CD25+FOXP3+ REGULATORY T CELLS |
| Q64911971 | Elucidating T Cell Activation-Dependent Mechanisms for Bifurcation of Regulatory and Effector T Cell Differentiation by Multidimensional and Single-Cell Analysis. |
| Q36486882 | Emerging possibilities in the development and function of regulatory T cells |
| Q57339016 | Enhanced efficacy of regulatory T cell transfer against increasing resistance, by elevated Foxp3 expression induced in arthritic murine hosts |
| Q36746537 | Enhanced tolerance to autoimmune uveitis in CD200-deficient mice correlates with a pronounced Th2 switch in response to antigen challenge |
| Q34147162 | Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells |
| Q37135741 | Enhancing therapeutic HPV DNA vaccine potency through depletion of CD4+CD25+ T regulatory cells |
| Q41873492 | Essential roles of CD8+CD122+ regulatory T cells in the maintenance of T cell homeostasis |
| Q41973912 | Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood |
| Q35990538 | Expansion of CD4+CD25+ suppressive regulatory T cells from rhesus macaque peripheral blood by FN18/antihuman CD28-coated Dynal beads |
| Q35684879 | Exploiting immune surveillance mechanisms in mucosal vaccine development |
| Q26779184 | Exploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer Immunotherapy |
| Q47339163 | Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia/lymphoma cells |
| Q43515102 | FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection |
| Q36243815 | FVIII-specific human chimeric antigen receptor T-regulatory cells suppress T- and B-cell responses to FVIII. |
| Q37620568 | Fallen angels or risen apes? A tale of the intricate complexities of imbalanced immune responses in the pathogenesis and progression of immune-mediated and viral cancers |
| Q80513353 | Fatal attraction: tumors beckon regulatory T cells |
| Q55391463 | Foxp3+ T Regulatory Cells: Still Many Unanswered Questions-A Perspective After 20 Years of Study. |
| Q45962826 | Fragile maintenance of allograft tolerance induced by lymphocyte sequestration and co-stimulation blockade. |
| Q35830699 | Functional Modulation of Regulatory T Cells by IL-2. |
| Q35848366 | Functional avidity directs T-cell fate in autoreactive CD4+ T cells |
| Q42619484 | Functional defects of peripheral regulatory T lymphocytes in patients with progressive vitiligo |
| Q36673290 | Functional dynamics of naturally occurring regulatory T cells in health and autoimmunity. |
| Q37705125 | Functional regulatory immune responses against human cartilage glycoprotein-39 in health vs. proinflammatory responses in rheumatoid arthritis. |
| Q35216458 | Generation and function of antigen-specific suppressor and regulatory T cells |
| Q26866523 | Graft rejection - endogenous or allogeneic? |
| Q36586957 | Guarding the immune system: suppression of autoimmunity by CD4+CD25+ immunoregulatory T cells |
| Q24802813 | HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells |
| Q35372836 | HIV-specific regulatory T cells are associated with higher CD4 cell counts in primary infection |
| Q39036180 | Harnessing bone marrow resident regulatory T cells to improve allogeneic stem cell transplant outcomes |
| Q37680540 | Harnessing regulatory T cells to suppress asthma: from potential to therapy |
| Q38122210 | Heat shock proteins can be targets of regulatory T cells for therapeutic intervention in rheumatoid arthritis |
| Q35131194 | Helminths and HIV infection: epidemiological observations on immunological hypotheses |
| Q35928393 | Hematopoietic chimerism and transplantation tolerance: a role for regulatory T cells. |
| Q36572935 | High distribution of CD40 and TRAF2 in Th40 T cell rafts leads to preferential survival of this auto-aggressive population in autoimmunity |
| Q35767591 | Higher Sensitivity of Foxp3+ Treg Compared to Foxp3- Conventional T Cells to TCR-Independent Signals for CD69 Induction |
| Q77342616 | Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo |
| Q34604828 | Homeostasis of intestinal immune regulation |
| Q56899646 | Homeostasis of peripheral FoxP3(+) CD4 (+) regulatory T cells in patients with early and late stage breast cancer |
| Q36251301 | Homeostatic T cell proliferation as a barrier to T cell tolerance |
| Q35317078 | Host immune responses that promote initial HIV spread |
| Q34378731 | How specificity for self-peptides shapes the development and function of regulatory T cells |
| Q37499321 | How the immune system achieves self-nonself discrimination during adaptive immunity |
| Q34529123 | Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. |
| Q41907086 | Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected]. |
| Q33942128 | Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro |
| Q36954734 | Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens |
| Q47963719 | Human CD4+CD25+ T cells derived from the majority of atopic donors are able to suppress TH1 and TH2 cytokine production |
| Q48193322 | Human Regulatory T Cells Mediate Transcriptional Modulation of Dendritic Cell Function. |
| Q40801370 | Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. |
| Q35024781 | Human plasmacytoid-derived dendritic cells and the induction of T-regulatory cells |
| Q99584371 | Human regulatory T cells (Treg) and their response to cancer |
| Q53212253 | Human regulatory T cells suppress proliferation of B lymphoma cells. |
| Q37387234 | Hydrodynamic vaccination with DNA encoding an immunologically privileged retinal antigen protects from autoimmunity through induction of regulatory T cells |
| Q46941757 | IDO expands human CD4+CD25high regulatory T cells by promoting maturation of LPS-treated dendritic cells |
| Q33382323 | IFN-gamma-dependent regulatory circuits in immune inflammation highlighted in diabetes |
| Q36673682 | IFN-γ-induced iNOS expression in mouse regulatory macrophages prolongs allograft survival in fully immunocompetent recipients |
| Q52918370 | IL-2 induces in vivo suppression by CD4(+)CD25(+)Foxp3(+) regulatory T cells. |
| Q41808550 | IL-2 receptor signaling is essential for the development of Klrg1+ terminally differentiated T regulatory cells |
| Q40831277 | IL-2-induced tumor necrosis factor (TNF)-beta expression: further analysis in the IL-2 knockout model, and comparison with TNF-alpha, lymphotoxin-beta, TNFR1 and TNFR2 modulation |
| Q36108954 | IL-33 Receptor-Expressing Regulatory T Cells Are Highly Activated, Th2 Biased and Suppress CD4 T Cell Proliferation through IL-10 and TGFβ Release |
| Q40044539 | IL-4 enhances IL-10 production in Th1 cells: implications for Th1 and Th2 regulation. |
| Q37078696 | IRF-4-binding protein inhibits interleukin-17 and interleukin-21 production by controlling the activity of IRF-4 transcription factor. |
| Q27485897 | Identification and In Vitro Expansion of Functional Antigen-Specific CD25+ FoxP3+ Regulatory T Cells in Hepatitis C Virus Infection |
| Q41988688 | Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood |
| Q43668975 | Identification of Treg-like cells in Tetraodon: insight into the origin of regulatory T subsets during early vertebrate evolution |
| Q61651904 | Identification of a CD4+CD25+ T?cell subset committedin vivoto suppress antigen-specific T?cell responses without additional stimulation |
| Q91195069 | Identification of the immunological profile in rejection-free heart transplantation |
| Q35141650 | Imaging regulatory T cell dynamics and CTLA4-mediated suppression of T cell priming |
| Q34842360 | Immature, but not inactive: the tolerogenic function of immature dendritic cells |
| Q80523271 | Immune modulation induced by tuberculosis DNA vaccine protects non-obese diabetic mice from diabetes progression |
| Q37993738 | Immune modulation of inflammatory conditions: regulatory T cells for treatment of GvHD. |
| Q35216470 | Immune regulation by CD4+CD25+ regulatory T cells: implications for transplantation tolerance |
| Q34400439 | Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance |
| Q38032611 | Immune responses in dogs with cutaneous adverse food reactions. |
| Q36909564 | Immune tolerance: mechanisms and application in clinical transplantation |
| Q35190921 | Immunization of patients with metastatic melanoma using both class I- and class II-restricted peptides from melanoma-associated antigens |
| Q34374572 | Immunologic self tolerance maintained by T-cell-mediated control of self-reactive T cells: implications for autoimmunity and tumor immunity |
| Q37864694 | Immunologic unresponsiveness to alloantigen in vivo: a role for regulatory T cells |
| Q37802002 | Immunological aspect of cardiac remodeling: T lymphocyte subsets in inflammation-mediated cardiac fibrosis |
| Q36626285 | Immunopathogenesis of IBD: insufficient suppressor function in the gut? |
| Q34223137 | Immunophenotyping |
| Q26775212 | Immunoregulation in human malaria: the challenge of understanding asymptomatic infection |
| Q35683325 | Immunoregulatory T cells in autoimmunity |
| Q35755276 | Immunoregulatory control of Th1/Th2 cytokine profiles in periodontal disease |
| Q33930475 | Immunosuppression by CD4+ regulatory T cells induced by chronic retroviral infection |
| Q36768976 | Immunotherapeutic strategies for high-risk bladder cancer |
| Q38857841 | Immunotherapy after hematopoietic stem cell transplantation using umbilical cord blood-derived products |
| Q36162929 | Immunotherapy of malignant brain tumors |
| Q24816789 | Impaired development of CD4+ CD25+ regulatory T cells in the absence of STAT1: increased susceptibility to autoimmune disease |
| Q45401711 | Impaired function of CD4+/CD25+ T regulatory lymphocytes characterizes the self-limited hepatitis A virus infection. |
| Q44791984 | Impaired regulatory T cell reconstitution in patients with acute graft-versus-host disease and cytomegalovirus infection after allogeneic bone marrow transplantation |
| Q80516143 | Importance of CD80/CD86-CD28 interactions in the recognition of target cells by CD8+CD122+ regulatory T cells |
| Q84660581 | In vitro human TGF-β treatment converts CD4+CD25− T cells into induced T regulatory like cells |
| Q36747712 | In vitro-generated antigen-specific CD4+ CD25+ Foxp3+ regulatory T cells control the severity of herpes simplex virus-induced ocular immunoinflammatory lesions |
| Q45884432 | In vitro-generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact allergy and systemic autoimmunity |
| Q36537036 | In vivo activation of transferred regulatory T cells specific for third-party exogenous antigen controls GVH disease in mice |
| Q35171080 | In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro |
| Q51966110 | In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption. |
| Q84683585 | Increased CD127 expression on activated FOXP3+CD4+ regulatory T cells |
| Q51561292 | Inducible and naturally occurring regulatory T cells enhance lung allergic responses through divergent transcriptional pathways. |
| Q83965091 | Induction of CD4(+)CD25(+)Foxp3(-) regulatory T cells by Thy-1 stimulation of CD4(+) T cells |
| Q35024784 | Induction of anergic and regulatory T cells by plasmacytoid dendritic cells and other dendritic cell subsets |
| Q47240621 | Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells |
| Q40530227 | Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes |
| Q34983446 | Induction of immune tolerance by dendritic cells: implications for preventative and therapeutic immunotherapy of autoimmune disease |
| Q80577057 | Induction of immunosuppressive functions of dendritic cells in vivo by CD4+CD25+ regulatory T cells: role of B7-H3 expression and antigen presentation |
| Q42944333 | Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells |
| Q41908906 | Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells |
| Q36997773 | Inflammation and repair in viral hepatitis C. |
| Q37096361 | Inflammation in lung carcinogenesis: new targets for lung cancer chemoprevention and treatment |
| Q27023584 | Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions |
| Q39188242 | Influence of CD4+CD25+ T cells on Plasmodium berghei NK65 infection in BALB/c mice |
| Q79447368 | Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic hepatitis B |
| Q34610052 | Injury induces early activation of T-cell receptor signaling pathways in CD4+ regulatory T cells. |
| Q37401280 | Innate and adaptive immunity for the pathobiology of Parkinson's disease |
| Q27008625 | Interaction between natural killer cells and regulatory T cells: perspectives for immunotherapy |
| Q47291768 | Interleukin-2 blocks the antitumour activity caused by depletion of CD25 cells in a murine renal adenocarcinoma model |
| Q45823097 | Interleukin-7 matures suppressive CD127(+) forkhead box P3 (FoxP3)(+) T cells into CD127(-) CD25(high) FoxP3(+) regulatory T cells. |
| Q33896888 | Intracellular MHC class II controls regulatory tolerance to allogeneic transplants |
| Q37350865 | Is there a feudal hierarchy amongst regulatory immune cells? More than just Tregs |
| Q92802463 | LKB1 expressed in dendritic cells governs the development and expansion of thymus-derived regulatory T cells |
| Q30441305 | Large functional repertoire of regulatory T-cell suppressible autoimmune T cells in scurfy mice |
| Q80097552 | Large-scale expansion of rat CD4+ CD25+ T(reg) cells in the absence of T-cell receptor stimulation |
| Q39127345 | Loss of Tolerance and Autoimmunity Affecting Multiple Organs inSTAT5A/5B-Deficient Mice |
| Q39837005 | Low molecular weight fraction secreted by SKOV3 cells expands peripheral CD4+CD25+ regulatory T cells and enhances their suppressive capacity |
| Q36186406 | Lymphocyte Activation Markers in Pediatric Kidney Transplant Recipients |
| Q36278295 | MHC class II derived recombinant T cell receptor ligands protect DBA/1LacJ mice from collagen-induced arthritis |
| Q36942521 | Manipulation of regulatory T-cell number and function with CD28-specific monoclonal antibodies |
| Q36399167 | Massive thymic deletion results in systemic autoimmunity through elimination of CD4+ CD25+ T regulatory cells |
| Q26753106 | Mechanisms of T cell organotropism |
| Q26850457 | Mechanisms underlying the induction of regulatory T cells and its relevance in the adaptive immune response in parasitic infections |
| Q39778135 | Memory CD4+ T cells do not induce graft-versus-host disease |
| Q42210265 | Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo |
| Q33962548 | Modeling the effector - regulatory T cell cross-regulation reveals the intrinsic character of relapses in Multiple Sclerosis |
| Q44632333 | Modulation of tryptophan catabolism by regulatory T cells. |
| Q38008361 | Molecular mechanisms of treg-mediated T cell suppression |
| Q36121878 | Mycobacterium tuberculosis infection interferes with HIV vaccination in mice |
| Q37593413 | Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis |
| Q53523527 | Natural Tregs, CD4+CD25+ inhibitory hybridomas, and their cell contact dependent suppression. |
| Q36570451 | Natural and induced regulatory T cells: targets for immunotherapy of autoimmune disease and allergy |
| Q34374592 | Natural regulatory CD4 T cells expressing CD25. |
| Q36423940 | Natural regulatory T cells and persistent viral infection |
| Q51986019 | Naturally arising CD4+CD25+ regulatory T cells suppress the expansion of colitogenic CD4+CD44highCD62L- effector memory T cells. |
| Q39120608 | Neonatal bacillus Calmette-Guérin vaccination inhibits de novo allergic inflammatory response in mice via alteration of CD4+CD25+ T-regulatory cells |
| Q36337433 | Neonatal regulatory T cells have reduced capacity to suppress dendritic cell function |
| Q36013722 | New strategy for testing efficacy of immunotherapeutic compounds for diabetes in vitro. |
| Q26782713 | Non-Neuronal Acetylcholine: The Missing Link Between Sepsis, Cancer, and Delirium? |
| Q34299829 | Non-Th2 regulatory T-cell control of Th1 autoimmunity |
| Q35595880 | Nonapoptotic and extracellular activity of granzyme B mediates resistance to regulatory T cell (Treg) suppression by HLA-DR-CD25hiCD127lo Tregs in multiple sclerosis and in response to IL-6. |
| Q36938431 | Ocular regulatory T cells distinguish monophasic from recurrent autoimmune uveitis |
| Q34408309 | Optimal isolation of functional Foxp3+ induced regulatory T cells using DEREG mice |
| Q33921576 | Oral tolerance, an active immunologic process mediated by multiple mechanisms |
| Q74381747 | Origin of regulatory T cells with known specificity for antigen |
| Q37312476 | Outgrowth of CD4low/negCD25+ T cells with suppressor function in CD4+CD25+ T cell cultures upon polyclonal stimulation ex vivo |
| Q34971545 | PARP-1 controls immunosuppressive function of regulatory T cells by destabilizing Foxp3 |
| Q43129860 | PSK may suppress CD57(+) T cells to improve survival of advanced gastric cancer patients |
| Q77704341 | Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals |
| Q33979892 | Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis |
| Q34801855 | Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases |
| Q41446869 | Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs. |
| Q42418046 | Patients with relapsing-remitting multiple sclerosis have normal Treg function when cells expressing IL-7 receptor alpha-chain are excluded from the analysis |
| Q37937040 | Pemphigus autoimmunity: hypotheses and realities |
| Q30436735 | Pervasive and stochastic changes in the TCR repertoire of regulatory T-cell-deficient mice |
| Q34313811 | Phenotypic characterization of regulatory T cells in the human decidua. |
| Q36439969 | Phenotypic complexity of T regulatory subsets in patients with B-chronic lymphocytic leukemia |
| Q35925641 | Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase |
| Q36470364 | Polyclonal CD4+Foxp3+ Treg cells induce TGFβ-dependent tolerogenic dendritic cells that suppress the murine lupus-like syndrome |
| Q35932423 | Polyclonal Recipient nTregs Are Superior to Donor or Third-Party Tregs in the Induction of Transplantation Tolerance |
| Q37269905 | Polyclonal Treg cells modulate T effector cell trafficking |
| Q34585878 | Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes |
| Q36127345 | Prevention of allograft rejection by amplification of Foxp3(+)CD4(+)CD25(+) regulatory T cells |
| Q35739397 | Process of hepatic metastasis from pancreatic cancer: biology with clinical significance |
| Q37915679 | Progress in haploidentical stem cell transplantation |
| Q34328457 | Progress on new vaccine strategies for the immunotherapy and prevention of cancer |
| Q37146446 | Proliferative assays for T cell function |
| Q40241029 | Quantitation of Anaplasma marginale major surface protein (MSP)1a and MSP2 epitope-specific CD4+ T lymphocytes using bovine DRB3*1101 and DRB3*1201 tetramers |
| Q42392644 | Raf signaling but not the ERK effector SAP-1 is required for regulatory T cell development |
| Q30437887 | Rapid and selective expansion of nonclonotypic T cells in regulatory T cell-deficient, foreign antigen-specific TCR-transgenic scurfy mice: antigen-dependent expansion and TCR analysis |
| Q33629928 | Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia |
| Q42461722 | Redox status and immune function in type I diabetes families |
| Q40397422 | Reduced circulating CD4+CD25+ cell populations in haemorrhagic fever with renal syndrome |
| Q37583435 | Reduction of retrovirus-induced immunosuppression by in vivo modulation of T cells during acute infection |
| Q36378338 | Regulating immunity to malaria |
| Q36631649 | Regulating regulatory T cells |
| Q34241129 | Regulating the immune response to transplants. a role for CD4+ regulatory cells? |
| Q42947652 | Regulatory CD4+CD25+ T cells restrict memory CD8+ T cell responses |
| Q73482464 | Regulatory CD8+ T cells control thyrotropin receptor-specific CD4+ clones in healthy subjects |
| Q90575102 | Regulatory T Cells Restrict Permeability to Bacterial Antigen Translocation and Preserve Short-Chain Fatty Acids in Experimental Cirrhosis |
| Q35129539 | Regulatory T Cells in the Control of Transplantation Tolerance and Autoimmunity |
| Q26995751 | Regulatory T cell in stroke: a new paradigm for immune regulation |
| Q33862770 | Regulatory T cell induction during Plasmodium chabaudi infection modifies the clinical course of experimental autoimmune encephalomyelitis. |
| Q54304204 | Regulatory T cell properties of thymic CD4+CD25+ cells in ducks. |
| Q36570665 | Regulatory T cells and systemic lupus erythematosus. |
| Q36969926 | Regulatory T cells and toll-like receptors: regulating the regulators |
| Q30493249 | Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease |
| Q35029947 | Regulatory T cells control HIV replication in activated T cells through a cAMP-dependent mechanism |
| Q37469657 | Regulatory T cells directed to the site of the action |
| Q35621984 | Regulatory T cells for tolerance therapy: revisiting the concept |
| Q37798839 | Regulatory T cells in HBV and HCV liver diseases: implication of regulatory T lymphocytes in the control of immune response |
| Q27001221 | Regulatory T cells in arterivirus and coronavirus infections: do they protect against disease or enhance it? |
| Q34547120 | Regulatory T cells in experimental autoimmune disease |
| Q36534833 | Regulatory T cells in graft-versus-host disease. |
| Q36419022 | Regulatory T cells in lupus |
| Q36321305 | Regulatory T cells in ovarian cancer: biology and therapeutic potential |
| Q24816793 | Regulatory T cells in rheumatoid arthritis |
| Q89910768 | Regulatory T cells in solid organ transplantation |
| Q36038429 | Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer |
| Q34348983 | Regulatory T cells in the control of immune pathology. |
| Q38619815 | Regulatory T cells in the immunotherapy of melanoma |
| Q35092535 | Regulatory T cells in transplantation tolerance |
| Q34786943 | Regulatory T cells in transplantation. |
| Q37691776 | Regulatory T cells in transplantation: does extracellular adenosine triphosphate metabolism through CD39 play a crucial role? |
| Q47154701 | Regulatory T cells induced by B cells: a novel subpopulation of regulatory T cells |
| Q36157898 | Regulatory T cells induced by ultraviolet radiation |
| Q38640091 | Regulatory T cells inhibit CD34+ cell differentiation into NK cells by blocking their proliferation. |
| Q33236315 | Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo |
| Q91045864 | Regulatory T cells mediate specific suppression by depleting peptide-MHC class II from dendritic cells |
| Q37412624 | Regulatory T cells overturned: the effectors fight back |
| Q37452133 | Regulatory T cells require renal antigen recognition through the TCR to protect against injury in nephritis |
| Q34531452 | Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide |
| Q36212936 | Regulatory T cells that recognize a ubiquitous stress-inducible self-antigen are long-lived suppressors of autoimmune arthritis |
| Q36430144 | Regulatory T cells, tumour immunity and immunotherapy |
| Q36911411 | Regulatory T cells--the renaissance of the suppressor T cells. |
| Q37593768 | Regulatory T cells: how do they suppress immune responses? |
| Q36484595 | Regulatory T cells: present facts and future hopes. |
| Q35384216 | Regulatory T-cell Trafficking: From Thymic Development to Tumor-Induced Immune Suppression |
| Q37981846 | Regulatory T-cell abnormalities and the global epidemic of immuno-inflammatory disease |
| Q36421407 | Regulatory T-cell compartmentalization and trafficking |
| Q36563537 | Regulatory T-cell physiology and application to treat autoimmunity |
| Q37302327 | Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? |
| Q36548414 | Regulatory T-cells in the control of immunological diseases |
| Q34792489 | Reprogramming the immune system |
| Q42536113 | Requirement for diverse TCR specificities determines regulatory T cell activity in a mouse model of autoimmune arthritis |
| Q37916797 | Retinoic acid generates regulatory T cells in experimental transplantation |
| Q37074537 | Retrovirus-specificity of regulatory T cells is neither present nor required in preventing retrovirus-induced bone marrow immune pathology |
| Q35705245 | Revival of the regulatory T cell: new targets for drug development |
| Q36738543 | Role and mechanisms of CD4+CD25+ regulatory T cells in the induction and maintenance of transplantation tolerance |
| Q73322515 | Role of CD4+CD25+ regulatory T cells from naive host thymus in the induction of acquired transplant tolerance by immunization with allo-major histocompatibility complex peptide.1 |
| Q35769939 | Role of autoimmunity in organ allograft rejection: a focus on immunity to type V collagen in the pathogenesis of lung transplant rejection |
| Q26799169 | Role of regulatory T-cells during hepatitis C infection: From the acute phase to post-transplantation recurrence |
| Q37143643 | SHIP limits immunoregulatory capacity in the T-cell compartment. |
| Q30436912 | SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels |
| Q35101987 | SLAP deficiency enhances number and function of regulatory T cells preventing chronic autoimmune arthritis in SKG mice |
| Q79249028 | Schistosoma japonicum egg antigens stimulate CD4 CD25 T cells and modulate airway inflammation in a murine model of asthma |
| Q50498827 | Selective action of the photosensitizer QLT0074 on activated human T lymphocytes. |
| Q40663440 | Selective intestinal decontamination with norfloxacin enhances a regulatory T cell-mediated inflammatory control mechanism in cirrhosis. |
| Q37179446 | Selective priming and expansion of antigen-specific Foxp3- CD4+ T cells during Listeria monocytogenes infection. |
| Q38088289 | Seminal fluid and the generation of regulatory T cells for embryo implantation. |
| Q44418597 | Sequential Involvement of Two Distinct CD4+ Regulatory T Cells during the Course of Transplantable Tumor Growth and Protection from 3–Methylcholanthrene‐induced Tumorigenesis by CD25–depletion |
| Q37550184 | Soluble OX40L and JAG1 Induce Selective Proliferation of Functional Regulatory T-Cells Independent of canonical TCR signaling |
| Q38244094 | Somatically mutated tumor antigens in the quest for a more efficacious patient-oriented immunotherapy of cancer |
| Q37043725 | Special regulatory T-cell review: A rose by any other name: from suppressor T cells to Tregs, approbation to unbridled enthusiasm |
| Q33736744 | Specificity of CD4+CD25+ regulatory T cell function in alloimmunity |
| Q34032006 | Specificity requirements for selection and effector functions of CD25+4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. |
| Q39402895 | Spectrum of T-lymphocyte activities regulating allergic lung inflammation |
| Q42906446 | Stimulation of α7 Nicotinic Acetylcholine Receptor by Nicotine Increases Suppressive Capacity of Naturally Occurring CD4+CD25+Regulatory T Cells in Mice In Vitro |
| Q34572198 | Strategies for designing and optimizing new generation vaccines |
| Q90700436 | Successful Salvage Haploidentical Alpha-Beta T Cell-Depleted Stem Cell Transplantation After Busulfan-Based Myeloablation in a Patient With IPEX Syndrome: A Case Report |
| Q56903922 | Superantigen-Induced Regulatory T Cells Display Different Suppressive Functions in the Presence or Absence of Natural CD4+CD25+ Regulatory T Cells In Vivo |
| Q35762936 | Supplementation of CD4+CD25+ regulatory T cells suppresses experimental autoimmune uveoretinitis |
| Q33359540 | Suppression of HIV-specific and allogeneic T cell activation by human regulatory T cells is dependent on the strength of signals |
| Q30388030 | Suppression of Th2 and Tfh immune reactions by Nr4a receptors in mature T reg cells |
| Q51690359 | Suppression of allergen reactive Th2 mediated responses and pulmonary eosinophilia by intranasal administration of an immunodominant peptide is linked to IL-10 production. |
| Q39413297 | Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells |
| Q34602996 | Suppressive oligodeoxynucleotides promote the generation of regulatory T cells by inhibiting STAT1 phosphorylation |
| Q37290190 | Suppressor T cells regulate the nonanergic cell population that remains after peripheral tolerance is induced to the Mls-1 antigen in T cell receptor Vbeta 8.1 transgenic mice |
| Q34014450 | Suppressor T cells: Rebirth, function and homeostasis |
| Q35849305 | Suppressor activity and potency among regulatory T cells is discriminated by functionally active CD44 |
| Q36376333 | Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses |
| Q26823613 | T Cells: Soldiers and Spies--The Surveillance and Control of Effector T Cells by Regulatory T Cells |
| Q34171890 | T cell-macrophage interactions and granuloma formation in vasculitis. |
| Q35063959 | T cells at the site of autoimmune inflammation show increased potential for trogocytosis |
| Q27469830 | T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. |
| Q36425917 | T regulatory cells as an immunotherapy for transplantation |
| Q35199844 | T-cell specific defect in expression of the NTPDase CD39 as a biomarker for lupus |
| Q35589560 | T-helper cell tolerance to ubiquitous nuclear antigens |
| Q35885273 | TCR affinity and specificity requirements for human regulatory T-cell function |
| Q36041794 | TCR signaling fuels T(reg) cell suppressor function |
| Q33901013 | TGF-beta-induced myelin peptide-specific regulatory T cells mediate antigen-specific suppression of induction of experimental autoimmune encephalomyelitis |
| Q54641474 | TGF-beta1 production by CD4+ CD25+ regulatory T cells is not essential for suppression of intestinal inflammation. |
| Q28263622 | TGF-beta: a mobile purveyor of immune privilege |
| Q37696079 | TNF-alpha: an activator of CD4+FoxP3+TNFR2+ regulatory T cells. |
| Q80143450 | TRAF6 is a T cell-intrinsic negative regulator required for the maintenance of immune homeostasis |
| Q38224804 | TREG-cell therapies for autoimmune rheumatic diseases. |
| Q93024302 | Targeting Stem Cell-Derived Tissue-Associated Regulatory T Cells for Type 1 Diabetes Immunotherapy |
| Q36310443 | Targeting T lymphocytes for immune monitoring and intervention in autoimmune diabetes |
| Q37519919 | Teladorsagia circumcincta in the sheep abomasum: defining the role of dendritic cells in T cell regulation and protective immunity |
| Q53351188 | Telomere length of in vivo expanded CD4(+)CD25 (+) regulatory T-cells is preserved in cancer patients. |
| Q36992773 | The Critical Role of TGF-beta1 in the Development of Induced Foxp3+ Regulatory T Cells |
| Q37475929 | The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients |
| Q37364109 | The T-cell receptor repertoire of regulatory T cells |
| Q64256609 | The Tolerogenic Function of Regulatory T Cells in Pregnancy and Cancer |
| Q64235834 | The absolute counts of peripheral T lymphocyte subsets in patient with ankylosing spondylitis and the effect of low-dose interleukin-2 |
| Q33953206 | The causative H+/K+ ATPase antigen in the pathogenesis of autoimmune gastritis. |
| Q38008355 | The cellular and molecular mechanisms of immuno-suppression by human type 1 regulatory T cells |
| Q83194650 | The cellular basis of cardiac allograft rejection. IX. Ratio of naïve CD4+CD25+ T cells/CD4+CD25- T cells determines rejection or tolerance |
| Q35058547 | The complementary roles of deletion and regulation in transplantation tolerance |
| Q34413247 | The contribution of immune and glial cell types in experimental autoimmune encephalomyelitis and multiple sclerosis |
| Q34308870 | The contributions of T-cell anergy to peripheral T-cell tolerance |
| Q37274250 | The development and function of regulatory T cells |
| Q34573771 | The enemy within: keeping self-reactive T cells at bay in the periphery |
| Q42944882 | The immune regulatory function of lymphoproliferative double negative T cells in vitro and in vivo. |
| Q34338802 | The immune tolerance network and rheumatic disease: immune tolerance comes to the clinic |
| Q34216426 | The immunological and genetic basis of inflammatory bowel disease |
| Q36078710 | The immunomodulatory effects of regulatory T cells: implications for immune regulation in the skin |
| Q84963758 | The impact of CD4+Foxp3+ Treg on immunity to murine cytomegalovirus after bone marrow transplantation depends on the peripheral or thymic source of T cell regeneration |
| Q36384707 | The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation |
| Q27024956 | The importance of regulatory T-cell heterogeneity in maintaining self-tolerance |
| Q36882243 | The influence of IL-2 family cytokines on activation and function of naturally occurring regulatory T cells |
| Q35916845 | The influence of commensal bacteria on infection with enteric viruses |
| Q28257250 | The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells |
| Q35928046 | The molecular mechanisms of regulatory T cell immunosuppression |
| Q38514428 | The neoplastically transformed (CD30hi) Marek's disease lymphoma cell phenotype most closely resembles T-regulatory cells |
| Q44781094 | The potency of allospecific Tregs cells appears to correlate with T cell receptor functional avidity. |
| Q24806216 | The potential of human regulatory T cells generated ex vivo as a treatment for lupus and other chronic inflammatory diseases |
| Q34009654 | The power and the promise of restimulation-induced cell death in human immune diseases |
| Q30429749 | The protein tyrosine phosphatase SHP-1 modulates the suppressive activity of regulatory T cells |
| Q39342581 | The psychoneuroendocrine-immunotherapy of cancer: Historical evolution and clinical results |
| Q34604823 | The puzzling world of murine T regulatory cells. |
| Q36141498 | The role of CD8+CD28 regulatory cells in suppressing myasthenia gravis-associated responses by a dual altered peptide ligand |
| Q36747499 | The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease |
| Q34096248 | The role of different subsets of T regulatory cells in controlling autoimmunity |
| Q35107549 | The role of regulatory T cells in controlling immunologic self-tolerance |
| Q37738676 | The role of regulatory T cells in respiratory infections and allergy and asthma. |
| Q47688707 | The role of regulatory cells in miniature swine rendered tolerant to cardiac allografts by donor kidney cotransplantation |
| Q35547512 | The role of the combination of IL-2 and TGF-β or IL-10 in the generation and function of CD4+ CD25+ and CD8+regulatory T cell subsets |
| Q34103905 | The role of the thymus in tolerance |
| Q36535760 | The role of virus-induced regulatory T cells in immunopathology |
| Q73867591 | The temporal importance of TNFalpha expression in the development of diabetes |
| Q36593753 | The tumor-draining lymph node as an immune-privileged site |
| Q52674851 | Therapeutic Potential of Gene-Modified Regulatory T Cells: From Bench to Bedside. |
| Q38098467 | Therapeutic potential of regulatory T cells in autoimmune disorders. |
| Q82771162 | Therapeutic potential of self-antigen-specific CD4+ CD25+ regulatory T cells selected in vitro from a polyclonal repertoire |
| Q38805382 | Therapy implications of the role of interleukin-2 in cancer |
| Q36719265 | Thymic deletion and regulatory T cells prevent antimyeloperoxidase GN. |
| Q61679981 | Tolerance and immunity in a mathematical model of T-cell mediated suppression |
| Q38256369 | Tolerance in organ transplantation: from conventional immunosuppression to extracellular vesicles. |
| Q35711560 | Tolerance mechanisms and recent progress |
| Q36903097 | Tolerance signaling molecules and pregnancy: IDO, galectins, and the renaissance of regulatory T cells. |
| Q34786072 | Tolerance through bone marrow transplantation with costimulation blockade |
| Q35987374 | Tolerance, suppression and the fetal allograft |
| Q35541149 | Tolerance-inducing strategies in transplantation surgery?current status and perspectives |
| Q34264024 | Toll-like receptor 2 controls expansion and function of regulatory T cells |
| Q37186819 | Toll-like receptor signalling on Tregs: to suppress or not to suppress? |
| Q43676127 | Tonsillar CD4+CD25+ regulatory T cells from IgA nephropathy patients have decreased immunosuppressive activity in experimental IgA nephropathy rats |
| Q36563528 | Transforming growth factor-beta and T-cell-mediated immunoregulation in the control of autoimmune diabetes |
| Q35180160 | Transforming growth factor-beta as a regulator of site-specific T-cell inflammatory response |
| Q39367491 | Transfusion-related immunomodulation and cancer |
| Q35107006 | Transplantation tolerance: Clinical potential of regulatory T cells |
| Q46602988 | Treatment of Uveitis by In Situ Administration of Ex Vivo-Activated Polyclonal Regulatory T Cells. |
| Q99726047 | Treg Enhancing Therapies to Treat Autoimmune Diseases |
| Q36914881 | Treg in type 1 diabetes |
| Q37105550 | Treg inducing adjuvants for therapeutic vaccination against chronic inflammatory diseases |
| Q34273253 | Treg lymphocytes in autoimmune uveitis. |
| Q57811623 | Tregitope-linked Refined Allergen Vaccines for Immunotherapy in Cockroach Allergy |
| Q35609371 | Tregs and infections: on the potential value of modifying their function |
| Q45401519 | Tumor necrosis factor alpha inhibits the suppressive effect of regulatory T cells on the hepatitis B virus-specific immune response |
| Q46463050 | Type II monocytes modulate T cell-mediated central nervous system autoimmune disease |
| Q34292787 | Unaltered negative selection and Treg development of self-reactive thymocytes in TCR transgenic Fyn-deficient mice |
| Q52561017 | Unmasking immunosurveillance against a syngeneic colon cancer by elimination of CD4+ NKT regulatory cells and IL-13. |
| Q37190443 | Unravelling the association of partial T-cell immunodeficiency and immune dysregulation |
| Q30498716 | Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice |
| Q41897453 | WASP regulates suppressor activity of human and murine CD4(+)CD25(+)FOXP3(+) natural regulatory T cells |
| Q36762514 | When three is not a crowd: a Crossregulation model of the dynamics and repertoire selection of regulatory CD4+ T cells. |
| Q79997853 | [Regulatory T cells] |
| Q80618997 | [Regulatory cells] |
Search more.